CT Calcium Scoring for Aortic Stenosis
velocity (Vmax), mean gradient, and aortic valve area (AVA). 2 The latter is less flow dependent and can be indexed to body surface area 2 In the majority of patients, these measurements provide concordant assessments, and the severity of AS is clear. However, in around a quarter of cases, these measures are discordant, creating confusion as to the true severity of AS and difficulties in clinical decision making. 3, 4 An independent, complementary test that could be used to arbitrate the true severity of AS would, therefore, have major clinical utility and potentially improve patient care. 5 In recent years, computed tomography aortic valve calcium scoring (CT-AVC) has emerged as a potential solution to this problem. Calcification is the predominant driver of AS [6] [7] [8] and can be readily quantified using the same approach as coronary CT calcium scoring. 9 Several studies have demonstrated an association between CT-AVC and hemodynamic measures of stenosis severity on echocardiography with women appearing to require less calcium to develop severe stenosis than men. [10] [11] [12] Recently, sex-specific CT-AVC thresholds have been proposed (women 1274 Agatston unit [AU] and men 2065 AU) to identify severe AS, as well as predicting disease progression and adverse clinical events. 3, 13 This has led to great interest in using CT-AVC as an alternative assessment of AS severity and as an umpire test in patients with discordant echocardiographic findings.
14 Although CT calcium scoring has recently been recommended in the latest European Society of Cardiology guidelines (for patients with low flow and low ejection fraction with no demonstrable flow reserve on dobutamine stress echocardiography), it is not part of American Heart Association/American College of Cardiology guidelines, and before it enters routine clinical use, its widespread clinical applicability needs to be established. 15 The aim of this study was to investigate the clinical utility and generalizability of CT-AVC in an international multicenter registry incorporating a wide range of patient populations, different scanner vendors, and varied image analysis platforms. Specifically, we sought to determine the ability of CT-AVC to identify severe AS in those with concordant echocardiographic measures to establish the ability of this technique to predict clinical outcomes and to arbitrate disease severity in patients with discordant echocardiographic findings.
Methods
The data and analytic methods have been made available for purposes of reproducing the results or replicating the procedure. Eight international centers were invited to contribute clinical, CT and echocardiography data from patients with AS into a multicenter registry (Table I in the Data Supplement). Patients were required to have at least mild AS (peak aortic jet velocity, >2.5 m/s or mean gradient >10 mm Hg) and to have undergone ECG-gated CT calcium scoring within 3 months of the echocardiogram. Patients with established rheumatic heart disease, other forms of valvular heart disease of at least moderate severity, or an estimated glomerular filtration rate <30 mL/min per 1.73 m 2 were excluded. Three centers contributed data from 5 prospective AS clinical research studies: Edinburgh Heart Centre, Edinburgh, United Kingdom, Hôpital Bichat, Paris, France, and Institut Universitaire de Cardiologie et de Pneumologie, Québec City, Québec, Canada. Two centers (Paris and Quebec) had previously published CT-AVC thresholds, 3 but here provided separate distinct populations of patients that did not overlap with their original cohort. The remaining 5 centers contributed data from patients in Europe and North America who were being considered for transcatheter aortic valve implantation and were undergoing CT scans as part of their work up (Table  I in 
Computed Tomography Aortic Valve Calcium Scoring
All centers performed noncontrast CT scans gated from 75% to 80% of the R-R interval, with a tube current of 42 to 1312 A and a voltage of 120 kV. Imaging was performed on a range of different scanners ( Table I in the Data Supplement). At the discretion of the attending clinician, some centers administered β-blockade to achieve a resting heart rate of ≤65 beats per minute (Amiens, France, and Edinburgh, United Kingdom).
Image analysis was performed locally using a range of different software packages (Table I in the Data Supplement). At the initiation of the study, consensus was reached on the optimum method for calcium scoring, and this was then applied at each of the centers, ensuring consistency of approach. In brief, CT-AVC scores were quantified on contiguous 3-mm axial slices commencing at the base of the valve, with care taken to exclude calcium originating from extravalvular structures, such as the mitral valve annulus, the ascending aorta, and coronary arteries ( Figure I in the Data Supplement). The total AVC in AU was calculated and subsequently indexed to the body surface area (AU/m 2 ) or divided by the echocardiographic measurement of the left ventricular outflow tract area to estimate calcium density (AU/cm 2 ).
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Echocardiography
Echocardiography was performed according to the European Association of Cardiovascular Imaging and American Society of Echocardiography guidelines with measurements of the Vmax (m/s), mean gradient (mm Hg), and AVA (cm 2 ) made for each patient. . 17 The sex-specific CT-AVC thresholds were then applied to these discordant patients to arbitrate whether they had severe or nonsevere disease ( Figure II in the Data Supplement).
Prediction of Disease Progression and Adverse Outcomes
The primary outcome was the time to first event of death or AVR post-CT calcium scoring. AVR included both open surgical procedures and transcatheter AVR. Decisions about whether to proceed to AVR were independent of CT-AVC and after multidisciplinary discussion. Patients in whom a decision to refer for AVR had already been made at the time of CT-AVC or who had CT imaging performed as part of the work up before transcatheter AVR or surgery were excluded from outcomes analysis.
Statistical Analysis
Continuous variables were expressed as mean±SD or median (interquartile range) as appropriate. CT-AVC data underwent square root transformation to achieve normality (√AU). Categorical data were presented as number and percentage. Correlations between continuous variables were assessed with linear regression analysis and either Pearson r or Spearman ρ. Parametric (unpaired Student t test) and nonparametric (Mann-Whitney U) tests were used as appropriate. One-way ANOVA was used to test for significant differences within multiple independent groups. In patients with concordant echocardiographic data, receiver operator curves were derived to assess CT-AVC thresholds and to identify the optimum thresholds for severe AS. Kaplan-Meier curves and Cox proportional hazards regression analyses were used to determine the ability of CT-AVC to predict adverse clinical events. Where appropriate, collinearity of variables was assessed before inclusion in the multivariable model. Two-sided significance was taken as P<0.05.
Results
Data were collated from 918 patients across 8 international centers (age, 77±10 years; 60% men; 6% bicuspid; Vmax, 3.88±0.90 m/s; Table 1 ) with 431 patients undergoing imaging within prospective clinical research studies and 487 patients being imaged as part of routine clinical care. The latter group included 366 patients being considered for transcatheter AVR who were excluded from outcome analyses. (Table II in the Data Supplement) . When subdivided by sex, women had lower CT-AVC to achieve the same degree of hemodynamic obstruction than men even after indexing for body surface area or the left ventricular outflow tract area (AVC calcium density).
Patients With Concordant Echocardiography
Performance of CT-AVC Thresholds Overall, 708 (77%) patients had concordant echocardiographic assessments of their disease severity (defined using the Vmax and AVA). Patients with concordant-severe disease (n=437) had AVC scores that were more than double patients with concordant nonsevere disease (n=272; P<0.001). In these concordant patients, we determined that the optimum CT-AVC thresholds for severe AS were 1377 AU for women and 2062 AU for men (Figure 1) . These thresholds had a sensitivity of 87% and specificity of 84% in women and a sensitivity of 80% and a specificity of 82% in men. This provided a high degree of discrimination for identifying severe AS (Figure 2 ). Overall the C-statistic for CT-AVC in thediagnosis of severe AS were 0.92 in women and 0.89 in men (Table 2) . CT-AVC performed similarly well when echocardiographic disease severity was defined using mean gradient ≥40 mm Hg and AVA index ≤0.6 cm 2 (C statistic: 0.93 women, 0.92 men; Table 3 ). Although the CT-AVC density also performed well, our optimum value in women (420 AU/cm 2 ) was different to that previously proposed (292 AU/cm 2 ). On this basis, the subsequent outcomes analyses were performed using values for CT-AVC only.
Prediction of Adverse Outcomes
Clinical outcome data were available in 215 (23%) patients after a median of 1029 (126-2251) days. Compared with the cohort as whole, these patients were more likely to be men and were younger (73±9 versus 79±10 years). They had less severe AS as measured using peak aortic jet velocity (3.4 versus 4.0 m/s), AVA ( Figure 3 ).
Patients With Discordant Echocardiography
A total of 210 (23%) patients in this study had discordant echocardiographic assessments of disease severity: 79 with low flow and 131 with normal flow (Table 1 ; Figure 4 ; Figure  II in the Data Supplement). Considerable heterogeneity in CT-AVC scores was observed in these patients with 102 (49%) having severe calcification and 108 (51%) having nonsevere calcification. This heterogeneity persisted to differing extents in each of the subgroups examined, with overall significantly different CT-AVC scores (P<0.001) between the subgroups (Figure 4 ). Within the low-flow category, 4 patients did not Within the discordant subgroup, outcomes were available in 41 patients in whom 17 patients were adjudicated to have reached the primary end point. On univariate analysis, severe CT-AVC was associated with an increase in the likelihood of AVR and death (HR, 3.67 [95% CI, 1.39-9.73]; P=0.010). On multivariable analysis, severe CT-AVC was once more an independent predictor of adverse outcomes (HR, 3.31 [95% CI, 1.10-9.94]; P=0.03) after adjustment for age, sex, and Vmax ≥ 4 m/s.
Performance of Previously Published CT-AVC Thresholds
We repeated our analyses using the previously published CT-AVC thresholds, (women, 1274 AU and men, 2065 AU), which were nearly identical to the present thresholds. 3 In women, the threshold of 1274 AU had a sensitivity of 89% and specificity 81%. Similarly, in men the threshold of 2065 AU had a sensitivity of 80% and a specificity of 82% ( The mean gradient and indexed aortic valve area were used to adjudicate stenosis severity. Clavel et al refers to thresholds proposed in reference 3 . AU indicates Agatston unit; and AUC, area under curve. The peak velocity and aortic valve area were used to adjudicate stenosis severity. Clavel et al refers to thresholds proposed in reference 3 . AU indicates Agatston unit; and AUC, area under curve. CT Calcium Scoring for Aortic Stenosis When applied to the discordant population, the published thresholds reclassified 4 patients so that numbers with severe calcification within each subgroup were as follows: 34 patients (54%) with paradoxical low flow; 8 (50%) with classical low-flow AS; 27 (77%) with a high Vmax >4.0 m/s (AVA >1.0 cm 
Discussion
In a multicenter international registry, we present the largest study to date simultaneously investigating both CT-AVC and echocardiography in patients with AS. We have demonstrated that sex-specific thresholds for CT-AVC are highly reproducible across different patient populations and demonstrate excellent discrimination for detecting severe AS. Moreover, we have demonstrated for the first time that CT-AVC thresholds are a powerful independent predictor of adverse clinical events, including among the subgroup of patients with discordant echocardiography. Given that CT-AVC is widely available, requires no contrast, and involves low radiation exposure, we think it should be used as a complementary imaging test alongside echocardiography, particularly in the high proportion of AS patients with discordant echocardiographic measurements and uncertain disease severity.
The identification of severe AS is essential because in those patients with symptoms, this diagnosis often triggers major cardiac surgery and AVR. CT-AVC holds promise as an alternative assessment of disease severity to complement echocardiography with the advantage that it is independent of loading conditions and hemodynamic influences. CT-AVC thresholds for severe AS have recently been proposed from a derivation cohort comprising 451 patients, demonstrating good agreement with echocardiography and the prediction Figure 3 . Sex-specific thresholds (1377 Agatston unit [AU] in women and 2062 AU in men) for severe calcification using computed tomography aortic valve calcification (CT-AVC) predict death and aortic valve replacement in patients with aortic stenosis. A, KaplanMeier Curves demonstrating event-free survival using the sex-specific thresholds for severe CT-AVC. Severe calcification was associated with an adverse prognosis (log-rank P=0.002) compared with patients with nonsevere calcification. B, Forrest plot for multivariable analysis. Sex-specific CT-AVC thresholds emerged as the only independent predictor of aortic valve replacement and death. Patients with a severe CT-AVC had a 3-to 4-fold increase in these events. AVA indicates aortic valve area; CI, confidence interval; HR, hazard ratio; and Vmax, peak aortic jet velocity. CT Calcium Scoring for Aortic Stenosis of clinical events in the same population. 13, 19 However, these thresholds had not previously been validated in an independent multicenter cohort, and it was unclear whether they were reproducible or generalizable in different patient populations or influenced by variations in imaging technology and analysis software. The primary objective of this study was to validate CT-AVC in AS in an independent international multicenter cohort and to investigate its widespread clinical applicability. We included patients from a variety of clinical settings, across 5 countries, imaged on an array of different scanners, and analyzed locally using a spectrum of different analysis software. Moreover, we tested CT-AVC against all 4 of the recommended echocardiographic measurements of disease severity in widespread clinical practice.
By design, we included patients with a broad range of disease severity, recruited from multiple international centers population, and had imaging on a range of scanners from different vendors. Despite this heterogeneity, our thresholds (women 1377 AU and men 2062 AU) for severe disease were nearly identical to those originally proposed (women 1274 AU and men 2065 AU) and performed similarly well. Our data, therefore, confirm both the reproducibility and generalizability of these CT-AVC thresholds for severe disease and their clinical utility as an alternative assessment of disease severity. Moreover, CT-AVC assessments using the Agatston method is relatively quick, widely available on commercial software and familiar to reporting physicians.
Of primary importance is the ability of CT-AVC to predict clinical outcomes. Indeed, assessing how quickly patients with AS are likely to proceed to AVR and whether they are at risk of death are 2 major objectives in clinical practice. Echocardiographic estimation of valvular calcification has been overlooked as a measure of disease severity despite conferring powerful risk-prediction 6 because of difficulties in assessment and poor reproducibility. CT-AVC facilitates accurate, reproducible calcium quantification, 9 and in a large subgroup of our population in whom prospective outcome data were available, we have confirmed the powerful prognostic information that A score above the dotted line represents CT-AVC above the sex-specific threshold and therefore severe aortic valve calcification. A CT-AVC score below the dotted line represents CT-AVC below the sex-specific threshold and nonsevere calcification. Considerable heterogeneity in disease severity as assessed by CT-AVC was observed in all 4 subgroups of patients with discordant echocardiographic findings. Box and whiskers plot, error bars are from the 10th to 90th centile and the horizontal line represents the median value. B, Kaplan-Meier Curves demonstrating event free survival using sex-specific thresholds for severe CT-AVC amongst patients with discordant echocardiographic measurements. Severe calcification was associated with an adverse prognosis (log-rank P=0.007) compared with patients with nonsevere calcification. AVA indicates aortic valve area; EF, ejection fraction; and Vmax, peak aortic jet velocity. CT Calcium Scoring for Aortic Stenosis CT-AVC provides independent of standard echocardiographic and clinical variables. Indeed CT-AVC was associated with an ≈4-fold increase in AVR or death and emerged as the sole predictor of these events on multivariable analysis. This is despite the fact that decisions to refer for AVR were based on the echocardiographic assessments not CT-AVC scores, the results of which were unavailable to clinicians.
How then might CT-AVC be used in clinical practice? Consistent with previous studies, almost a quarter of our patients (n=210; 23%) had discordant echocardiographic measurements. In these patients, the severity of stenosis remained in question, and we explored whether CT-AVC might act as an arbitrator or umpire test. Our results suggest that there is substantial heterogeneity in disease severity in these discordant patients that persisted within each of the different subgroups examined. Given the lack of a gold standard assessment of disease severity in discordant patients, it is important to note that CT-AVC provided similarly powerful and independent Patients with severe calcification have a 3-to 4-fold increase in aortic valve replacement and death compared with those with nonsevere calcification (hazards ratio, 3.90 [95% confidence interval, 2.19-6.78]; P<0.001) after adjustment for age, sex, peak aortic jet velocity, and aortic valve area). CT Calcium Scoring for Aortic Stenosis prognostic information in these subjects as it did across the wider AS population (HR, 3-4 for AVR or death). This is the first time that this has been demonstrated and highlights the particular value that CT-AVC holds as both an arbitrator of disease severity and prognostic marker in this challenging and common cohort of patients ( Figure 5 ). Indeed we think that CT-AVC should be used as a robust and powerful guide to patient management in patients where diagnostic and prognostic uncertainty exists, either in combination or even in substitution to dobutamine stress echocardiography, which is not always easy to perform or interpret. Indeed, unlike advanced echocardiographic techniques that are more dependent on operator technique and expertise, the simplicity, generalizability, and reproducibility of CT-AVC lends itself to rapid application in the clinic. Importantly, we still think that echocardiography should remain the first-line diagnostic assessment in AS and that CT-AVC should only be used when the echocardiographic measures of severity are discordant.
Our study has some limitations. In the prospective clinical studies, patients with a wide range of AS disease severity were recruited; however, those patients undergoing CT scans for clinical indications by definition had more severe disease. Nonetheless, it is in precisely these patients that we anticipate CT-AVC scoring is most likely to be used. It is also important to note that while agreement with echocardiography was generally excellent in a small subgroup of patients, there was clear disagreement between the CT-AVC thresholds and concordant echocardiographic measures of severity. Further work is required to determine the prognostic ramifications of unexpectedly high (or low) calcium burdens in these patients and whether they have evidence of noncalcific valve thickening.
For the outcomes analysis, we had to exclude patients who were undergoing CT evaluation for aortic valve intervention because they would inevitably have AVR. Nevertheless, we were still able to assess clinical outcomes in patients recruited in to the prospective cohort studies. Indeed, our outcome cohort ultimately comprised 210 patients (considerably larger than for many comparable echocardiographic studies) and for the first time confirmed the prognostic importance of CT-AVC in patients with discordant echocardiography. Finally, we did not undertake core laboratory analyses of the CT-AVC because our intention instead was to assess the generalizability of CT-AVC as performed and analyzed in individual centers. Moreover, despite this lack of centralized standardization, CT-AVC continued to demonstrate highly consistent and reproducible thresholds, thereby underlining the clinical utility of this approach.
Conclusions
In this large multicenter international registry of nearly a thousand patients with AS, we have established the excellent reproducibility of sex-specific AVC thresholds and confirmed both their accuracy for severe AS and independent prognostic capability. On this basis, we think that CT-AVC is now ready for widespread clinical use as a complementary imaging test alongside echocardiography in patients with AS. We anticipate that its primary application would be to identify patients with severe AS in whom echocardiography provides conflicting readouts. These findings provide strong support to the integration of CT-AVC in routine practice for the management of AS.
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